DC-853
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DC-853, covering 2025-04-22 to 2025-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DC-853 in Healthy Participants [Phase 1]